• Contact Us
Friday, May 27, 2022
Health Business
Advertisement
  • Home
  • News
    Ebola vaccine approved by FDA

    Covid: Fourth-dose jab trial shows good boost

    Microbiology diagnostics: Removing the Kenyan antimicrobial resistance blindfold

    Microbiology diagnostics: Removing the Kenyan antimicrobial resistance blindfold

    Food apps and online gaming driving obesity – WHO

    Food apps and online gaming driving obesity – WHO

    Hepatitis detected in nearly 300 children worldwide

    Hepatitis detected in nearly 300 children worldwide

  • Events
  • Private
    • KHF
    • Providers
  • Government
    • Medical Research
    • Politics & Policy
    • Regulation, Enforcement & Compliance
  • Finance
  • Tech
  • Epaper
  • Videos
  • Home
  • News
    Ebola vaccine approved by FDA

    Covid: Fourth-dose jab trial shows good boost

    Microbiology diagnostics: Removing the Kenyan antimicrobial resistance blindfold

    Microbiology diagnostics: Removing the Kenyan antimicrobial resistance blindfold

    Food apps and online gaming driving obesity – WHO

    Food apps and online gaming driving obesity – WHO

    Hepatitis detected in nearly 300 children worldwide

    Hepatitis detected in nearly 300 children worldwide

  • Events
  • Private
    • KHF
    • Providers
  • Government
    • Medical Research
    • Politics & Policy
    • Regulation, Enforcement & Compliance
  • Finance
  • Tech
  • Epaper
  • Videos
No Result
View All Result
Health Business
No Result
View All Result

Coronavirus: Oxford University to resume vaccine trial after pause

by Health Business
September 17, 2020
in News
0
Coronavirus: Oxford University to resume vaccine trial after pause
Share This:

Trials of a Covid-19 vaccine being developed by AstraZeneca and Oxford University will resume after being paused due to a reported side effect in a patient in the UK.

On Tuesday, AstraZeneca said the studies were being paused while it investigated whether the adverse reaction was linked with the vaccine.

But on Saturday, the university said it had been deemed safe to continue.

Health Secretary Matt Hancock welcomed the news that the trials would resume.

“This pause shows we will always put safety first. We will back our scientists to deliver an effective vaccine as soon as safely possible,” he added.

The university said in a statement that it was “expected” that “some participants will become unwell” in large trials such as this one.

It added that the studies could now resume following the recommendations of an independent safety review committee and the UK regulator, the Medicines and Healthcare Products Regulatory Agency.

Share This:
Previous Post

The pandemic is an opportunity to change our health behaviour for good

Next Post

Scientists have identified seven lineages of SARS-CoV-2: why it matters

Related Posts

Ebola vaccine approved by FDA
News

Covid: Fourth-dose jab trial shows good boost

May 12, 2022
Microbiology diagnostics: Removing the Kenyan antimicrobial resistance blindfold
News

Microbiology diagnostics: Removing the Kenyan antimicrobial resistance blindfold

May 12, 2022
Food apps and online gaming driving obesity – WHO
News

Food apps and online gaming driving obesity – WHO

May 5, 2022
Next Post
COVID-19 vaccine: the challenges of running a trial in the middle of a pandemic

Scientists have identified seven lineages of SARS-CoV-2: why it matters

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

No Result
View All Result

Follow Us

Most Read

  • Microbiology diagnostics: Removing the Kenyan antimicrobial resistance blindfold

    Microbiology diagnostics: Removing the Kenyan antimicrobial resistance blindfold

    0 shares
    Share 0 Tweet 0
  • Understanding of low back pain with recent evidence

    0 shares
    Share 0 Tweet 0
  • Menopause: what are the symptoms and why does it happen?

    0 shares
    Share 0 Tweet 0
Health Business

Health Business contains need-to-know features, news and case studies that explain the administrative and commercial issues affecting healthcare and hospital management. Health Business supports several high profile exhibitions - coverage of which is always timed for maximum impact. Regular topics include ICT, Finance/Funding, Facilities Management, Security, Health & Safety. Contributors range from government ministers through to top-level health administrators and association chairs.

Top Stories

Ebola vaccine approved by FDA

Covid: Fourth-dose jab trial shows good boost

May 12, 2022
Microbiology diagnostics: Removing the Kenyan antimicrobial resistance blindfold

Microbiology diagnostics: Removing the Kenyan antimicrobial resistance blindfold

May 12, 2022
Food apps and online gaming driving obesity – WHO

Food apps and online gaming driving obesity – WHO

May 5, 2022

Interests

  • Events
  • Finance
  • Government
  • Magazines
  • Medical Research
  • News
  • Politics & Policy
  • Providers
  • Public Health
  • Regulation, Enforcement & Compliance
  • Technology
  • Videos

Follow Us

  • Contact Us

© 2019 | Site by Mark & Ryse.

No Result
View All Result
  • Home
  • News
  • Events
  • Private
    • KHF
    • Providers
  • Government
    • Medical Research
    • Politics & Policy
    • Regulation, Enforcement & Compliance
  • Finance
  • Tech
  • Epaper
  • Videos

© 2019 | Site by Mark & Ryse.